[Incidence and clinical features of some complications of typhoid fever during levomycetin therapy].
D000208:Acute Disease; D000328:Adult; D000818:Animals; D002701:Chloramphenicol / Q000627:therapeutic use*; D002764:Cholecystitis / Q000188:drug therapy / Q000209:etiology; D003864:Depression, Chemical; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D007416:Intestinal Perforation / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D007421:Intestine, Small; D051379:Mice; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D012480:Salmonella Infections / Q000517:prevention & control; D013997:Time Factors; D014435:Typhoid Fever / Q000150:complications* / Q000188:drug therapy
D002701:Chloramphenicol
Chastota i klinicheskaia kharakteristikanekotorykh oslozhneniĭ briushnogo tifa pri lechenii levomitsetinom.